Motus GI Holdings, Inc., a medical technology company, provides endoscopy solutions that enhance clinical outcomes and the cost-efficiency associated with colonoscopy in the United States and Israel. Its flagship product is the Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.
IPO Year: 2018
Exchange: NASDAQ
Website: motusgi.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/25/2023 | Buy → Neutral | Ladenburg Thalmann |
Ladenburg Thalmann downgraded Motus GI from Buy to Neutral
EFFECT - Motus GI Holdings, Inc. (0001686850) (Filer)
EFFECT - Motus GI Holdings, Inc. (0001686850) (Filer)
EFFECT - Motus GI Holdings, Inc. (0001686850) (Filer)
EFFECT - Motus GI Holdings, Inc. (0001686850) (Filer)
EFFECT - Motus GI Holdings, Inc. (0001686850) (Filer)
15-12G - Motus GI Holdings, Inc. (0001686850) (Filer)
S-8 POS - Motus GI Holdings, Inc. (0001686850) (Filer)
S-8 POS - Motus GI Holdings, Inc. (0001686850) (Filer)
S-8 POS - Motus GI Holdings, Inc. (0001686850) (Filer)
S-8 POS - Motus GI Holdings, Inc. (0001686850) (Filer)